Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Clinical Oncology|August 1, 1983
Cis-platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary. A phase II study of the Gynecologic Oncology GroupJ T Thigpen, L Lagasse, H Homesley, et al.
Investigational New Drugs|July 1, 1989
Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group StudyW P McGuire, J A Blessing, E Yordan, et al.
American Journal of Clinical Oncology|December 1, 1990
Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group studyG P Sutton, J A Blessing, W Barnes, et al.
Investigational New Drugs|January 1, 1986
A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)J Arseneau, J A Blessing, F B Stehman, et al.
American Journal of Clinical Oncology|February 1, 1997
Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix: a Gynecological Oncology Group studyS Lincoln, J A Blessing, R McGehee, et al.
Investigational New Drugs|January 1, 1986
A phase II study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)W P McGuire, J A Blessing, K Hatch, et al.
Cancer Treatment Reports|September 1, 1986
Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, W C Fowler, et al.
Gynecologic Oncology|October 1, 1996
Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group studyT Thigpen, J A Blessing, E Yordan, et al.
Gynecologic Oncology|October 19, 2001
Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group studyJ P Curtin, J A Blessing, J T Soper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group studyP G Rose, J A Blessing, D M Gershenson, et al.
Pageof 18